cellular therapy

Fringe medicine
(1) Live cell therapy.
(2) Cell therapy.

Mainstream medicine
Stem cell therapy.

Mentioned in ?

References in periodicals archive ?

TARA-002 is an investigational cellular therapy based on OK-432, an immunostimulant, currently approved in Japan and Taiwan, that has been the standard of care for LMs for over 20 years.

ArTara Therapeutics Starts New Immunology Pipeline Programme with TARA-002, a Toll-Like Receptor 4 Agonist, Targeting Rare Lymphatic Malformations

HemaCare is a global leader in the customization of human- derived biological products and services for biomedical research, drug discovery and cellular therapy process development.

HEMACARE & TISSUE SOLUTIONS FORM PARTNERSHIP

Acquiring this technology will allow Celling to combine their unique cellular therapy devices with the existing ThermiGen technology to offer physicians a unique scientific approach to treat their patience.

ALMIRALL SIGNS AGREEMENT TO DIVEST THERMIGEN

Actinium Pharmaceuticals announced that new data from the ongoing pivotal Phase 3 SIERRA trial for Iomab-B was reported in a late breaking oral presentation at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR that was held on February 20th - 24th.

Actinium Pharmaceuticals reports new data from Phase 3 SIERRA trial

The partnership will integrate Genentech's global cancer immunotherapy research and development leadership with Adaptive's proprietary T-cell receptor discovery and immune profiling platform to accelerate a transformational new treatment paradigm of tailoring cellular therapy for each patient's individual cancer.

Adaptive Biotechnologies signs worldwide collaboration and license agreement with Genentech

is a private Delaware corporation that leverages its globally integrated science, development and informatics teams to accelerate the design, high-throughput screening, discovery and development of adoptive cellular therapy candidates.

F1 Oncology Affiliate EXUMA biotechnology Acquires CAR-T Assets

MCKINNEY, MD, Assistant Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke

Therapy Is Clearly a Gamechanger in DLBCL

"The acquisition of Kite establishes Gilead as a leader in cellular therapy and provides a foundation from which to drive continued innovation for people with advanced cancers," said John F.

Gilead to Acquire Kite Pharma

Cord blood banking is believed to provide the stem cells needed to replace and regenerate damaged bone marrow, treat blood cancers, and be a potential source for cellular therapy and regenerative medicine.

Providing options for parents

The International Society for Cellular Therapy (Vancouver, B.C.), established in 1992, represents 1,300 clinicians, regulators, researchers, technologists and industry partners in 50 countries.

ARM-ISCT to collaborate on cell therapy projects

presents readers with a collection of contributions that discuss the current status of cellular therapy for a range of neurological disorders and injuries, including traumatic brain injury, ischemic and hemorrhagic stroke, and spinal cord injury.

Cellular Therapy for Neurological Injury

Medical browser ?

Full browser ?

CITE

Site: Follow: Share:

Open / Close